This topic contains a solution. Click here to go to the answer

Author Question: A patient treated with weekly chloroquine for malaria prophylaxis complains of abdominal discomfort ... (Read 94 times)

clippers!

  • Hero Member
  • *****
  • Posts: 828
A patient treated with weekly chloroquine for malaria prophylaxis complains of abdominal discomfort and nausea after taking each dose. The nurse should:
 
  a. instruct the patient to stop the medication.
  b. change the route to an intramuscular one.
  c. administer the medication intravenously.
  d. instruct the patient to take the medication with meals.

Question 2

Activation of which receptor subtype causes contraction of skeletal muscle?
 
  a. Alpha1
  b. Muscarinic
  c. Nicotinic
  d. Beta2



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bblaney

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

d

Answer to Question 2

c




clippers!

  • Member
  • Posts: 828
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


nanny

  • Member
  • Posts: 313
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library